Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Accounts Payables (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Accounts Payables data on record, last reported at $768000.0 in Q3 2025.

  • For Q3 2025, Accounts Payables fell 23.12% year-over-year to $768000.0; the TTM value through Sep 2025 reached $768000.0, down 23.12%, while the annual FY2024 figure was $696000.0, 9.49% down from the prior year.
  • Accounts Payables reached $768000.0 in Q3 2025 per UTMD's latest filing, up from $737000.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $1.5 million in Q1 2022 and bottomed at $511000.0 in Q3 2023.
  • Average Accounts Payables over 5 years is $956894.7, with a median of $914000.0 recorded in 2025.
  • Peak YoY movement for Accounts Payables: soared 111.79% in 2021, then plummeted 60.36% in 2023.
  • A 5-year view of Accounts Payables shows it stood at $761000.0 in 2021, then surged by 60.05% to $1.2 million in 2022, then tumbled by 36.86% to $769000.0 in 2023, then fell by 9.49% to $696000.0 in 2024, then rose by 10.34% to $768000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $768000.0 in Q3 2025, $737000.0 in Q2 2025, and $914000.0 in Q1 2025.